Treating Forms of MS With Ocrelizumab
Siponimod for Relapsing MS
First-Line Therapy for Multiple Sclerosis
Optimizing Treatment Selection in Multiple Sclerosis
Magnetic Resonance Imaging in Multiple Sclerosis
Implications of Revised McDonald Criteria in MS
A Redefined Classification of Multiple Sclerosis
The Etiology of Multiple Sclerosis
Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS
The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.
Stuart Isaacson, MD: The Essential Tremor Treatment Landscape
The director of the Parkinson's Disease and Movement Disorders Center of Boca Raton spoke to how a new generation of interventions has led to a shifting backdrop in the field of care in essential tremor.
Stuart Isaacson, MD: The Challenge of OFF Episodes in Parkinson Disease
The director of the Parkinson's Disease and Movement Disorders Center of Boca Raton spoke to the challenges which remain in addressing OFF episodes in treating Parkinson disease.
FDA Approves Eptinezumab, Ofatumumab Accepted for Supplemental Biologics License Application, Deutetrabenazine Fails in Tourette Syndrome
Neurology News Network for the week ending February 29, 2020.
Final Thoughts on MRI Guidelines and Protocols
Payer and Patient Education of the Standardized Examination
Impact of Insurance on Scanning and Patient Care
Barriers in Use of CMSC Protocol
Developing International Protocols and Standardized Scanners
PML Monitoring and Educating Technicians
Maintaining a Consistent Protocol and Scanner for MS
Treatment Modifications Based on Inflammatory Activity
MS Diagnosis: McDonald Criteria and Gadolinium
Role of Gadolinium and Central Vein Sign in MS Imaging
Evolution of MS MRI Guidelines and Alignment With MAGNIMS
FDA Approves Programmable Pump System for Spasticity, Revised Treatment Recommendations for Spinal Muscular Atrophy, OnabotulinumtoxinA Trial Results
Neurology News Network for the week ending February 22, 2020.
Adopting Neuromuscular Therapies for SMA
Ongoing Clinical Trials & Managing Patient Expectations
The Impact of the ENDEAR Trial Regimen
Psychological Effects of SMA on Children and Adults
Centers of Excellence and Future Oral Medication
Family Planning for People With SMA
